Tranexamic Acid
- Product NDC
- 70860-400
- 11-digit product format
- 708600400
- Labeler code
- 70860
- Product ID
- 70860-400_965bbf85-2808-4653-9f61-649d9667b52c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tranexamic acid
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Athenex Pharmaceutical Division, LLC.
- Application
- ANDA207239
- Marketing category
- ANDA
- Marketing start
- 2017-03-27
- Marketing end
- 0000-00-00
- Substance
- TRANEXAMIC ACID
- Active strength
- 100 mg/mL
- Pharmacologic classes
- Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70860-400-10 | 70860040010 | 10 VIAL in 1 CARTON (70860-400-10) > 10 mL in 1 VIAL (70860-400-41) | 10 vial | 2017-03-27 | 0000-00-00 | No | No | Current |